Skip to main content

Search

7 result(s) for 'author#"Fumiya Baba"' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. The treatment schedules for stereotactic body radiotherapy (SBRT) for lung cancer vary from institution to institution. Several reports have indicated that stage IB patients had worse outcomes than stage IA pa...

    Authors: Fumiya Baba, Yuta Shibamoto, Hiroyuki Ogino, Rumi Murata, Chikao Sugie, Hiromitsu Iwata, Shinya Otsuka, Katsura Kosaki, Aiko Nagai, Taro Murai and Akifumi Miyakawa

    Citation: Radiation Oncology 2010 5:81

    Content type: Research

    Published on:

  2. The overall treatment time of stereotactic body radiotherapy (SBRT) for non-small-cell lung cancer is usually 3 to over 10 days. If it is longer than 7 days, tumor volume expansion during SBRT may jeopardize t...

    Authors: Kotoha Tatekawa, Hiromitsu Iwata, Takatsune Kawaguchi, Satoshi Ishikura, Fumiya Baba, Shinya Otsuka, Akifumi Miyakawa, Maho Iwana and Yuta Shibamoto

    Citation: Radiation Oncology 2014 9:8

    Content type: Research

    Published on:

  3. In stereotactic body radiotherapy (SBRT) for lung tumors, reducing tumor movement is necessary. In this study, we evaluated changes in tumor movement and percutaneous oxygen saturation (SpO2) levels, and prelimin...

    Authors: Fumiya Baba, Yuta Shibamoto, Natsuo Tomita, Chisa Ikeya-Hashizume, Kyota Oda, Shiho Ayakawa, Hiroyuki Ogino and Chikao Sugie

    Citation: Radiation Oncology 2009 4:15

    Content type: Research

    Published on:

  4. Organizing pneumonia (OP), so called bronchiolitis obliterans organizing pneumonia after postoperative irradiation for breast cancer has been often reported. There is little information about OP after other ra...

    Authors: Taro Murai, Yuta Shibamoto, Takeshi Nishiyama, Fumiya Baba, Akifumi Miyakawa, Shiho Ayakawa, Hiroyuki Ogino, Shinya Otsuka and Hiromitsu Iwata

    Citation: Radiation Oncology 2012 7:123

    Content type: Research

    Published on:

  5. Radiation proctitis after intensity-modulated radiation therapy (IMRT) differs from that seen after pelvic irradiation in that this adverse event is a result of high-dose radiation to a very small area in the ...

    Authors: Shinya Takemoto, Yuta Shibamoto, Shiho Ayakawa, Aiko Nagai, Akihiro Hayashi, Hiroyuki Ogino, Fumiya Baba, Takeshi Yanagi, Chikao Sugie, Hiromi Kataoka and Mikio Mimura

    Citation: Radiation Oncology 2012 7:87

    Content type: Research

    Published on:

  6. Two prospective phase II trials were designed to assess the efficacy and safety of image-guided proton therapy (IGPT) for either medically inoperable or operable stage I non-small cell lung cancer (NSCLC). The...

    Authors: Koichiro Nakajima, Hiromitsu Iwata, Hiroyuki Ogino, Yukiko Hattori, Shingo Hashimoto, Toshiyuki Toshito, Kensuke Hayashi, Kenji Akita, Fumiya Baba, Katsumi Nakamae, Jun-etsu Mizoe and Yuta Shibamoto

    Citation: Radiation Oncology 2018 13:199

    Content type: Research

    Published on:

  7. Efficacy of stereotactic body radiotherapy (SBRT) in stage I non–small-cell lung cancer (NSCLC) has almost been established. In Japan, the protocol of 48 Gy in 4 fractions over 4 days has been most often emplo...

    Authors: Akifumi Miyakawa, Yuta Shibamoto, Fumiya Baba, Yoshihiko Manabe, Taro Murai, Chikao Sugie, Takeshi Yanagi and Taiki Takaoka

    Citation: Radiation Oncology 2017 12:152

    Content type: Research

    Published on: